The Federal Circuit limits the reach of the on sale bar and provides guidance to pharmaceutical companies that rely on the use of contract manufacturers. Bruce Haas and Lauren Zuffante discuss.
IAM Patent 1000 Continues to Recognize Venable’s IP Practice and Attorneys Among the Leaders in California, the DC Metro Area, Illinois, and New York for 2022